Reagents for
Diphtheria Vaccine Development
Diphtheria
is caused primarily by toxigenic Corynebacterium
diphtheriae
strains and occasionally by toxigenic C.
ulcerans
and C. pseudotuberculosis
strains. The acute respiratory infection caused by Diphtheria is generally
characterized by local growth of the bacterium in the pharynx with pseudomembrane
formation. Then, systemic dissemination of diphtheria toxin (DT) induces
lesions in distant organs. Diphtheria toxin is an exotoxin produced by the
pathogen that inhibits protein synthesis and causes cell death. The disease may
remain manageable, but in more severe cases, lymph nodes in the neck may swell,
making breathing and swallowing more difficult. Diphtheria can also lead to
paralysis of the eyes, neck, throat, or respiratory muscles. The CDC recommends
diphtheria vaccination for infants, children, teens, and adults.
Creative
Diagnostics has released new diphtheria vaccine-related products, including
antibodies, antigens and ELISA kits. The development and testing of diphtheria
vaccines has been enhanced using these reagents suitable for routine diagnosis
of diphtheria and epidemiological surveys.
Performance
Products Available
(주)엘바이오시스템은 Creative Diagnostics의 한국공식대리점입니다.
제품의 주문 및 관련정보가 필요하시면 전화, 이메일로 문의해 주세요.